Jennifer Litton, MD
Advertisement
Articles by Jennifer Litton, MD
Not only are PARP inhibitors proving to be an efficacious treatment for patients with metastatic breast cancer, but they're also improving quality of life, too.
Advertisement
Latest Updated Articles
Benefits of PARP Inhibitor Use in Breast CancerJanuary 11th 2019
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Nurses: The Lifeline for Dietitian Referrals in Cancer Care
2
Cancer Surgery Waiting Times Rising: What Oncology Nurses Need to Know
3
What Nurses Need to Know About FDA-Approved Iberdomide in Multiple Myeloma
4
How Iberdomide Approval Benefits Rural and Frail Multiple Myeloma Patients
5